REQUEST A DEMO
Total
USD $0.00
Search more companies

Oliclinic Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Department Stores | Electronic Shopping and Mail-Order Houses | Other Direct Selling Establishments | Offices of Dentists | General Medical and Surgical Hospitals
Full name: Oliclinic Sp. z o.o. Profile Updated: May 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Oliclinic Sp. z o.o. is an enterprise located in Poland, with the main office in Wroclaw. The company operates in the Ambulatory Health Care Services industry. It was incorporated on March 06, 2017. There was a net sales revenue increase of 17.09% reported in Oliclinic Sp. z o.o.’s latest financial highlights for 2022. A growth of 12.84% was recorded in its total assets. The net profit margin of Oliclinic Sp. z o.o. decreased by 4.18% in 2022.

Headquarters
Ul. Oliwkowa 14/1
Wroclaw; Dolnoslaskie; Postal Code: 54-054

Contact Details: Purchase the Oliclinic Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Oliclinic Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Oliclinic Sp. z o.o. report to view the information.
Incorporation Date:
March 06, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
99%
Company Performance
Financial values in the chart are available after Oliclinic Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
17.09%
Total operating revenue
17.09%
Operating profit (EBIT)
-12.03%
EBITDA
-14.77%
Net Profit (Loss) for the Period
-11.25%
Total assets
12.84%
Total equity
21.73%
Operating Profit Margin (ROS)
-5.03%
Net Profit Margin
-4.18%
Return on Equity (ROE)
-6.63%
Debt to Equity Ratio
-4.44%
Quick Ratio
5.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?